
The American Cancer Society (ACS) has officially updated its cervical cancer screening guidelines, marking one of the most significant shifts in women’s preventive health in recent years. The revised recommendations, released on December 4, move toward making screening more accessible, effective, and responsive to the latest scientific evidence.
Table of Content:-
Cervical cancer remains a global health problem, with an estimated 660,000 new cases and 350,000 deaths recorded in 2022. Though it is generally preventable, cervical cancer remains the fourth leading cause of cancer in women around the world, with almost 94% of the cases occurring in the low, and middle, income countries of the world. Experts say this gap is driven by limited access to HPV vaccination, timely screening, and early treatment.
Against this backdrop, the ACS has issued updated guidelines that may change how millions of women and people with a cervix approach cervical cancer prevention.
What are the New Cervical Cancer Screening Guidelines
The most groundbreaking change is the acceptance of self-collected vaginal samples for testing for HPV. For the first time, individuals can choose to self-collect specimens, either in a clinic or in the future, potentially at home, for primary HPV testing. Although clinician-collected samples remain the gold standard, this shift greatly broadens the net for those people who experience barriers such as lack of access to healthcare, discomfort with pelvic exams, or geographic constraints.
Another major update is that the exit criteria for stopping screening are now more clear and structured. ACS now offers specific guidelines on when it is safe for individuals to discontinue screening after age 65, thereby reducing confusion about when one can appropriately stop. ACS notes that these changes aim to improve compliance with screening without compromise on accuracy or early detection.
ALSO READ- Do Vaccines Really Prevent Cervical Cancer? Find Out Here

Who Needs Cervical Screening and When?
The new recommendations pertain to people with a cervix who are at average risk for cervical cancer.
- Start screening before the age 25: The ACS counters that cervical cancer is uncommon before age 25, and that earlier screening can lead to unnecessary procedures without additional benefit.
- Age 25-65: Screening should be done routinely during these years.
Preferred Screening Method of Cervical Screening and Intervals
ACS now recommends primary HPV testing every 5 years as the preferred method. HPV testing is more sensitive than traditional Pap tests. It can detect high-risk strains linked to cervical cancer even before changes would appear on a cytology test.
ALSO READ- Warning Signs Of Cancer In Women: Doctor Shares Unusual Changes To Watch Out For

If primary HPV testing is not available, ACS supports two alternatives:
- Co-testing (HPV + Pap) every 5 years
- Pap test alone every 3 years
For those choosing the newly recognized self-collected vaginal HPV test, a negative result means repeating it every 3 years, not 5. Clinician-collected samples continue to adhere to the 5-year interval.
Bottomline
The new ACS guidelines for cervical cancer screening move toward a future where access, early detection, and reduced barriers are most important, placing HPV testing at the forefront and self-collection as a major stride toward more inclusive preventive care.
Read Next
Ratan Tata’s Stepmother, Simone Tata, Dies at 95: Death Cause Said To Be Parkinson’s Complications
How we keep this article up to date:
We work with experts and keep a close eye on the latest in health and wellness. Whenever there is a new research or helpful information, we update our articles with accurate and useful advice.
Current Version
Dec 05, 2025 14:39 IST
Published By : Tanya Srivastava